Published in Arterioscler Thromb Vasc Biol on March 01, 1996
Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention? Cardiovasc Diabetol (2012) 0.98
TagSNP evaluation for the association of 42 inflammation loci and vascular disease: evidence of IL6, FGB, ALOX5, NFKBIA, and IL4R loci effects. Hum Genet (2006) 0.95
Cardiovascular risk in women with polycystic ovarian syndrome (PCOS). J Clin Pathol (2005) 0.93
Severity of obstructive sleep apnea is associated with elevated plasma fibrinogen in otherwise healthy patients. Sleep Breath (2014) 0.87
Elevated white cell count in acute coronary syndromes: relationship to variants in inflammatory and thrombotic genes. BMC Med Genet (2004) 0.81
Nitrated fibrinogen is a biomarker of oxidative stress in venous thromboembolism. Free Radic Biol Med (2012) 0.81
GHK and DNA: resetting the human genome to health. Biomed Res Int (2014) 0.77
Control of fibrinogen biosynthesis: role of the FFA/albumin ratio. Cardiovasc Eng (2010) 0.77
Effects of acipimox on haemorheology and plasma lipoproteins in patients with mixed hyperlipoproteinaemia. Br J Clin Pharmacol (1998) 0.75
New circulating biomarkers for predicting cardiovascular death in healthy population. J Cell Mol Med (2015) 0.75
Evaluation of Oxidative Stress and hsCRP in Polycystic Ovarian Syndrome in a Tertiary Care Hospital. Indian J Clin Biochem (2014) 0.75
Anthropometrically predicted visceral adipose tissue and blood-based biomarkers: a cross-sectional analysis. Eur J Nutr (2016) 0.75
Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet (2000) 6.19
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. JAMA (1998) 3.37
Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc Natl Acad Sci U S A (1998) 2.54
Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study. Arch Intern Med (1993) 2.43
In-hospital and 1-year mortality in 1,524 women after myocardial infarction. Comparison with 4,315 men. Circulation (1991) 2.13
Low total cholesterol is associated with high total mortality in patients with coronary heart disease. The Bezafibrate Infarction Prevention (BIP) Study Group. Eur Heart J (1997) 2.08
The Drosophila rolled locus encodes a MAP kinase required in the sevenless signal transduction pathway. EMBO J (1994) 2.06
Sex differences in management and outcome after acute myocardial infarction in the 1990s: A prospective observational community-based study. Israeli Thrombolytic Survey Group. Circulation (2000) 2.02
Long-term mortality follow-up of hospital survivors of a myocardial infarction randomized to nifedipine in the SPRINT study. Secondary Prevention Reinfarction Israeli Nifedipine Trial. Cardiovasc Drugs Ther (1998) 2.01
Self-reported physical activity predicts long-term coronary heart disease and all-cause mortalities. Twenty-one-year follow-up of the Israeli Ischemic Heart Disease Study. Arch Fam Med (1995) 1.96
Relation of serum total cholesterol and high-density lipoprotein cholesterol percentage to the incidence of definite coronary events: twenty-year follow-up of the Donolo-Tel Aviv Prospective Coronary Artery Disease Study. Am J Cardiol (1987) 1.78
Characteristics of smokers, non-smokers and ex-smokers among 10,000 adult males inIsrael. II. Physiologic, biochemical and genetic characteristics. Am J Epidemiol (1977) 1.78
High density lipoprotein cholesterol and incidence of coronary heart disease--the Israeli Ischemic Heart Disease Study. Am J Epidemiol (1979) 1.75
Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology (2004) 1.70
Major factors in the development of diabetes mellitus in 10,000 men. Arch Intern Med (1975) 1.62
Long-term prognosis of women after myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. Am J Epidemiol (1997) 1.62
Does diuretic therapy increase the risk of renal cell carcinoma? Am J Cardiol (1999) 1.60
Angina pectoris among 10,000 men. II. Psychosocial and other risk factors as evidenced by a multivariate analysis of a five year incidence study. Am J Med (1976) 1.58
Photonic information processing beyond Turing: an optoelectronic implementation of reservoir computing. Opt Express (2012) 1.57
Voluntary and involuntary weight loss: associations with long term mortality in 9,228 middle-aged and elderly men. Am J Epidemiol (1998) 1.56
Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-up. Cardiology (1999) 1.52
Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era. SPRINT and Thrombolytic Survey Groups. Circulation (1998) 1.47
Total and high density lipoprotein cholesterol in the serum and risk of mortality: evidence of a threshold effect. Br Med J (Clin Res Ed) (1985) 1.44
Mortality trends in men and women with acute myocardial infarction in coronary care units in Israel. A comparison between 1981-1983 and 1992-1994. For the SPRINT and the Israeli Thrombolytic Survey Groups. Eur Heart J (2000) 1.43
Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease. J Am Coll Cardiol (1999) 1.42
Primary ventricular tachycardia in acute myocardial infarction: clinical characteristics and mortality. The SPRINT Study Group. Ann Intern Med (1992) 1.41
Risk factors and segment-specific carotid arterial enlargement in the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke (1996) 1.41
Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. Benzafibrate Infarction Prevention (BIP) Study Research Group. J Am Coll Cardiol (1998) 1.40
Calcium antagonists and mortality in patients with coronary artery disease: a cohort study of 11,575 patients. J Am Coll Cardiol (1996) 1.40
Optimization of chemically defined cell culture media--replacing fetal bovine serum in mammalian in vitro methods. Toxicol In Vitro (2010) 1.39
Diabetes, prediabetes and uricaemia. Diabetologia (1976) 1.29
Factors related to diabetes incidence: a multivariate analysis of two years observation on 10,000 men. The Israel Ischemic Heart Disease Study. J Chronic Dis (1971) 1.28
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med (2009) 1.27
Uric acid and diabetes: observations in a population study. Lancet (1982) 1.24
Five-year myocardial infarction incidence. II. Association of single variables to age and birthplace. J Chronic Dis (1973) 1.22
Blood groups, myocardial infarction and angina pectoris among 10,000 adult males. N Engl J Med (1971) 1.22
Beneficial effect of magnesium sulfate in acute myocardial infarction. Am J Cardiol (1990) 1.21
Gingival hyperplasia caused by nifedipine--a preliminary report. Int J Cardiol (1984) 1.20
Prognostic significance of mild mitral regurgitation by color Doppler echocardiography in acute myocardial infarction. Am J Cardiol (2000) 1.18
Increased exploratory activity and altered response to LSD in mice lacking the 5-HT(5A) receptor. Neuron (1999) 1.18
Altered fear circuits in 5-HT(1A) receptor KO mice. Biol Psychiatry (2000) 1.17
Genetic aspects of arteriosclerosis. Arteriosclerosis (1986) 1.16
Unrecognized myocardial infarction: five-year incidence, mortality, and risk factors. Ann Intern Med (1976) 1.13
Elevated serum triglyceride levels and long-term mortality in patients with coronary heart disease: the Bezafibrate Infarction Prevention (BIP) Registry. Circulation (1999) 1.13
The epidemiology of coronary heart disease in the ethnically and culturally diverse population of Israel. A review. Isr J Med Sci (1982) 1.13
High-density lipoprotein cholesterol and risk of ischemic stroke mortality. A 21-year follow-up of 8586 men from the Israeli Ischemic Heart Disease Study. Stroke (1997) 1.12
Weight-height indices. Choice of the most suitable index and its association with selected variables among 10,000 adult males of heterogeneous origin. Br J Prev Soc Med (1974) 1.12
Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction. SPRINT Study Group. Eur Heart J (1992) 1.11
Diabetes mellitus among 10,000 adult men. I. Five-year incidence and associated variables. Isr J Med Sci (1974) 1.11
Impaired fasting glucose concentrations in nondiabetic patients with ischemic heart disease: a marker for a worse prognosis. Am Heart J (2001) 1.09
The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. J Clin Epidemiol (1995) 1.08
Improvement of parkinsonian features correlate with high plasma levodopa values after broad bean (Vicia faba) consumption. J Neurol Neurosurg Psychiatry (1992) 1.08
Evaluation of electrocardiogram in emergency room as a decision-making tool. Chest (1977) 1.08
The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Arthritis Rheum (2000) 1.07
The incidence of hypertension and associated factors: the Israel ischemic heart disease study. Am Heart J (1972) 1.06
Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Bezafibrate Infarction Prevention (BIP) Registry: high triglycerides constitute an independent risk factor. Circulation (2001) 1.05
Interval timing in genetically modified mice: a simple paradigm. Genes Brain Behav (2007) 1.05
Diagnostic laparoscopy: a 5-year experience in a hepatology training program. Am J Gastroenterol (1995) 1.04
Antihypertensive therapy and the risk of malignancies. Eur Heart J (2001) 1.04
Circadian variation and possible external triggers of onset of myocardial infarction. SPRINT Study Group. Am J Med (1993) 1.04
Malignant arrhythmias in relation to values of serum potassium in patients with acute myocardial infarction. Int J Cardiol (1991) 1.04
Characteristics of smokers, nonsmokers and ex-smokers among 10,000 adult males in Israel. I. Distribution of selected sociodemographic and behavioral variables and the prevalence of disease. Isr J Med Sci (1975) 1.03
Ten-year survival after acute myocardial infarction: comparison of patients with and without diabetes. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. Am Heart J (1997) 1.03